EcoDrugPlus

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSATEG00000018074
Gene Symbol: TGFBR1B
3 Cross references
205 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSATEG00000013090
Gene Symbol: TRPA1B
3 Cross references
201 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSATEG00000011970
Gene Symbol: TPH1A
3 Cross references
202 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSATEG00000024627
Gene Symbol: TTK
3 Cross references
204 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSATEG00000021606
Gene Symbol: TUBA4A
3 Cross references
158 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSATEG00000026630
Gene Symbol: LOC113163285
2 Cross references
144 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSATEG00000024282
Gene Symbol: LOC113167146
2 Cross references
126 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSATEG00000023934
Gene Symbol: LOC113171380
3 Cross references
301 Possible Orthologues:

Tubulin, Beta 1 Class Vi

Ensembl ID : ENSATEG00000025036
Gene Symbol: TUBB1
2 Cross references
184 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSATEG00000019516
Gene Symbol: TP53
2 Cross references
231 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSATEG00000019779
Gene Symbol: LOC113160258
2 Cross references
189 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSATEG00000007018
Gene Symbol: TYR
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).